Comprehensive Bioanalytical Solutions from Discovery to Clinical and Biomarker

We have been developing methods and analyzing bioanalytical samples for more than 15 years. We have over 130 scientists in 3 facilities located in the USA and China. Our senior scientists average 10 – 15 years in complex drug development and many come from leading Pharmaceutical companies. Over 70% of our scientists hold advanced degrees.

Our expertise includes development of more than 1,400 proprietary and non-proprietary methods and the yearly throughput of more than 500,000 samples analyzed in regulated, GLP and GCP settings.

Proven Quality. Better Decisions.

Our experience and performance metrics translate into the highest quality, reproducible bioanalytical data. Our bioanalytical laboratories are compliant with internal standard operating procedures (SOP), Good Laboratory Practice (GLP) and world health authority guidance. We have had more than 30 inspections by the FDA, WHO and Health Canada. Our audit history with regulatory authorities and client inspections is outstanding.